Ngā hua rapu kaituhi :: APM

1

Clinical characteristics, molecular profile and outcomes of myeloid sarcoma: a single institution experience over 13 years mā Varinder Kaur, Arjun Swami, Daisy Alapat, Al - Ola Abdallah, Pooja Motwani, Laura F. Hutchins, Yogesh Jethava

I whakaputaina 2017

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
2

Conditioning regimens for allogeneic hematopoietic stem cell transplants in acute myeloid leukemia mā Yogesh Jethava, Simona Sica, Bipin N. Savani, Francisco Socola, Madan Jagasia, Mohamad Mohty, Arnon Nagler, Andrea Bacigalupo

I whakaputaina 2017

Whiwhi kuputuhi katoa
Revisão

Tiaki ki tētahi rārangi

I tiakina i:
3

Destabilizing NEK2 overcomes resistance to proteasome inhibition in multiple myeloma mā Reinaldo Franqui-Machin, Mu Hao, Hua Bai, Zhimin Gu, Xin Zhan, Hasem Habelhah, Yogesh Jethava, Lugui Qiu, Ivana Frech, Guido Tricot, Fenghuang Zhan

I whakaputaina 2018

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
4

Alteration of mitochondrial biogenesis promotes disease progression in multiple myeloma mā Xin Zhan, Wenjie Yu, Reinaldo Franqui-Machin, Melissa L. Bates, Kalyan Nadiminti, Huojun Cao, Brad A. Amendt, Yogesh Jethava, Ivana Frech, Fenghuang Zhan, Guido Tricot

I whakaputaina 2017

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
5

Four genes predict high risk of progression from smoldering to symptomatic multiple myeloma (SWOG S0120) mā Rashid Z Khan, Madhav V. Dhodapkar, Adam Rosenthal, Christoph Heuck, Xanthos Papanikolaou, Pingping Qu, Frits van Rhee, M. Zangari, Yogesh Jethava, Joshua Epstein, Shmuel Yaccoby, Antje Hoering, John Crowley, Nathan Petty, Clyde Bailey, Gareth J. Morgan, Bart Barlogie

I whakaputaina 2015

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
6

Inhibiting MEK in MAPK pathway-activated myeloma mā Christoph Heuck, Yogesh Jethava, Rashid Z Khan, Frits van Rhee, Maurizio Zangari, Shweta S. Chavan, Kelly R. Robbins, Scott E. Miller, Aasiya Matin, Meera Mohan, Siraj M. Ali, P. J. Stephens, Jeffrey S. Ross, V.A. Miller, Faith E. Davies, Bart Barlogie, Gareth J. Morgan

I whakaputaina 2015

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Carta

Tiaki ki tētahi rārangi

I tiakina i:
7

Identification and Characterization of Tumor-Initiating Cells in Multiple Myeloma mā Minjie Gao, Hua Bai, Yogesh Jethava, Yujie Wu, Yuqi Zhu, Ye Yang, Jiliang Xia, Huojun Cao, Reinaldo Franqui-Machin, Kalyan Nadiminti, Gregory S. Thomas, Mohamed E. Salama, Peter Altevogt, Gail A. Bishop, Michael H. Tomasson, Siegfried Janz, Jumei Shi, Lijuan Chen, Ivana Frech, Guido Tricot, Fenghuang Zhan

I whakaputaina 2019

Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
8

ELRANATAMAB, A B-CELL MATURATION ANTIGEN-CD3 BISPECIFIC ANTIBODY, FOR PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA: EXTENDED FOLLOW UP AND BIWEEKLY ADMINISTRATION FROM THE MA... mā Mohamad Mohty, Michael H. Tomasson, Bertrand Arnulf, Nizar J. Bahlis, Martin Prince, Rubén Niesvizky, P Rodrgue-Otero, J Martine-Lopez, Guenther Koehne, Yogesh Jethava, Afshin Eli Gabayan, Don A. Stevens, Ajay K. Nooka, Noopur Raje, S Iida, Eric Leip, U. Conte, Akos Czibere, Andrea Viqueira, Vivian Blunk, Alexander M. Lesokhin

I whakaputaina 2023

Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
9

$Efficacy and Safety of Elranatamab in Patients with Relapsed/Refractory Multiple Myeloma Naïve to B-Cell Maturation Antigen (BCMA)-Directed Therapies: Results from Cohort a of the Magnetismm-3 Study$

Efficacy and Safety of Elranatamab in Patients with Relapsed/Refractory Multiple Myeloma Naïve to B-Cell Maturation Antigen (BCMA)-Directed Therapies: Results from Cohort a of the... mā Nizar J. Bahlis, Michael H. Tomasson, Mohamad Mohty, Rubén Niesvizky, Ajay K. Nooka, Salomon Manier, Christopher Maisel, Yogesh Jethava, Joaquín Martínez‐López, H. Miles Prince, Bertrand Arnulf, Paula Rodríguez‐Otero, Guenther Koehne, Cyrille Touzeau, Noopur Raje, Shinsuke Iida, Marc‐Steffen Raab, Eric Leip, Sharon T. Sullivan, Umberto Conte, Andrea Viqueira, Alexander M. Lesokhin

I whakaputaina 2022

Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
10

$Elranatamab in relapsed or refractory multiple myeloma: phase 2 MagnetisMM-3 trial results$

Elranatamab in relapsed or refractory multiple myeloma: phase 2 MagnetisMM-3 trial results mā Alexander M. Lesokhin, Michael H. Tomasson, Bertrand Arnulf, Nizar J. Bahlis, H. Miles Prince, Rubén Niesvizky, Paula Rodríguez‐Otero, Joaquín Martínez‐López, Guenther Koehne, Cyrille Touzeau, Yogesh Jethava, Hang Quach, Julien Depaus, Hisayuki Yokoyama, Afshin Eli Gabayan, Don A. Stevens, Ajay K. Nooka, Salomon Manier, Noopur Raje, Shinsuke Iida, Marc S. Raab, Emma Searle, Eric Leip, Sharon T. Sullivan, Umberto Conte, Mohamed Elmeliegy, Akos Czibere, Andrea Viqueira, Mohamad Mohty

I whakaputaina 2023

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
11

Autologous Transplantation in Follicular Lymphoma with Early Therapy Failure: A National LymphoCare Study and Center for International Blood and Marrow Transplant Research Analysis mā Carla Casulo, Jonathan W. Friedberg, Kwang Woo Ahn, Christopher R. Flowers, Alyssa DiGilio, Sonali M. Smith, Sairah Ahmed, David J. Inwards, Mahmoud Aljurf, Andy I. Chen, Hannah Choe, Jonathon B. Cohen, Edward A. Copelan, Umar Farooq, Timothy S. Fenske, César O. Freytes, Sameh Gaballa, Siddhartha Ganguly, Yogesh Jethava, Rammurti T. Kamble, Vaishalee P. Kenkre, Hillard M. Lazarus, Aleksandr Lazaryan, Richard F. Olsson, Andrew R. Rezvani, David A. Rizzieri, Sachiko Seo, Gunjan L. Shah, Nina Shah, Melham Solh, Anna Sureda, Basem M. William, Aaron Cumpston, Andrew D. Zelenetz, Brian K. Link, Mehdi Hamadani

I whakaputaina 2017

Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i: